+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liver Cirrhosis Drug"

Liver Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Liver Cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
From
From
From
From
Liver Cirrhosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Liver Cirrhosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
US Liver Cirrhosis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Liver Cirrhosis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
Liver Cirrhosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Liver Cirrhosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 158 Pages
  • Global
From
Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021 - Product Thumbnail Image

Liver Cirrhosis (Gastrointestinal) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 178 Pages
  • Global
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Liver Cirrhosis is a chronic liver disease caused by the accumulation of scar tissue in the liver. It is a progressive condition that can lead to liver failure and death. Treatment for liver cirrhosis includes lifestyle changes, medications, and in some cases, surgery. Medications used to treat liver cirrhosis include antiviral drugs, antibiotics, antifibrotic drugs, and immunosuppressants. These drugs are used to reduce inflammation, reduce the risk of infection, and slow the progression of the disease. The Liver and Kidney Disorders Drugs market is a rapidly growing segment of the pharmaceutical industry. This market includes drugs used to treat a variety of liver and kidney disorders, including liver cirrhosis. These drugs are used to reduce inflammation, reduce the risk of infection, and slow the progression of the disease. Some companies in the Liver Cirrhosis Drug market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Show Less Read more